Watch for Cabenuva, a New Monthly Injectable for HIV
March 2021
Cabenuva (cabotegravir/rilpivirine) will be the first MONTHLY antiretroviral treatment for adults living with HIV.
It’s given as two IM gluteal injections at the same visit. Each Cabenuva kit has one vial of cabotegravir, an integrase inhibitor...and one vial of rilpivirine, a non-nucleoside reverse transcriptase inhibitor.
Viral load suppression with Cabenuva seems similar to standard 3-med oral DAILY regimens, such as Biktarvy or Triumeq.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote